CoChat

Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development

Open access
Li, Zening, Hui, Jianan, Yang, Panhui, Mao, Hongju · 2022 · Biosensors
Cited by 120

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

An organ-on-a-chip is a device that combines micro-manufacturing and tissue engineering to replicate the critical physiological environment and functions of the human organs. Therefore, it can be used to predict drug responses and environmental effects on organs. Microfluidic technology can control micro-scale reagents with high precision. Hence, microfluidics have been widely applied in organ-on-chip systems to mimic specific organ or multiple organs in vivo. These models integrated with various sensors show great potential in simulating the human environment. In this review, we mainly introduce the typical structures and recent research achievements of several organ-on-a-chip platforms. We also discuss innovations in models applied to the fields of pharmacokinetics/pharmacodynamics, nano-medicine, continuous dynamic monitoring in disease modeling, and their further applications in other fields.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/bios12060370

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 92

  1. Mitchell, 2001, Microfluidics—Downsizing large-scale biology, Nat. Biotechnol., 19, 717, 10.1038/90754 · DOI · Paper page
  2. Mark, 2010, Microfluidic lab-on-a-chip platforms: Requirements, characteristics and applications, Chem. Soc. Rev., 39, 1153, 10.1039/b820557b · DOI · Paper page
  3. Kartalov, 2007, Experimentally validated quantitative linear model for the device physics of elastomeric microfluidic valves, J. Appl. Phys., 101, 64505, 10.1063/1.2511688 · doi:10.1063/1.2511688
  4. Thorsen, 2004, Microfluidic tools for high-throughput screening, Biotechniques, 36, 197, 10.2144/04362TE01 · DOI
  5. Manz, 1992, Planar chips technology for miniaturization and integration of separation techniques into monitoring systems, J. Chromatogr. A, 593, 253, 10.1016/0021-9673(92)80293-4 · DOI · Paper page
  6. Thorsen, 2002, Microfluidic large-scale integration, Science, 298, 580, 10.1126/science.1076996 · DOI · Paper page
  7. Hyejin, 2003, Creating, transporting, cutting, and merging liquid droplets by electrowetting-based actuation for digital microfluidic circuits, J. Microelectromech. Syst., 12, 70, 10.1109/JMEMS.2002.807467 · DOI · Paper page
  8. Zhang, 2017, Point-of-care-testing of nucleic acids by microfluidics, TrAC Trends Anal. Chem., 94, 106, 10.1016/j.trac.2017.07.013 · DOI · Paper page
  9. Shehab, 2016, US Emergency Department Visits for Outpatient Adverse Drug Events, 2013–2014, JAMA, 316, 2115, 10.1001/jama.2016.16201 · DOI · Paper page
  10. McLean, 2018, Powering ex vivo tissue models in microfluidic systems, Lab Chip, 18, 1399, 10.1039/C8LC00241J · DOI
  11. McConnell, 1992, The cytosensor microphysiometer: Biological applications of silicon technology, Science, 257, 1906, 10.1126/science.1329199 · DOI · Paper page
  12. Park, 2003, Integration of cell culture and microfabrication technology, Biotechnol. Prog., 19, 243, 10.1021/bp020143k · DOI · Paper page
  13. Esch, 2011, The role of body-on-a-chip devices in drug and toxicity studies, Annu. Rev. Biomed. Eng., 13, 55, 10.1146/annurev-bioeng-071910-124629 · DOI · Paper page
  14. Nakao, 2011, Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device, Biomicrofluidics, 5, 22212, 10.1063/1.3580753 · DOI · Paper page
  15. Jang, 2013, Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment, Integr. Biol., 5, 1119, 10.1039/c3ib40049b · DOI · Paper page
  16. An, 2016, A Laminated Microfluidic Device for Comprehensive Preclinical Testing in the Drug ADME Process, Sci. Rep., 6, 25022, 10.1038/srep25022 · DOI · Paper page
  17. Franco, 2012, Tissue engineering: Blood vessels on a chip, Nature, 488, 465, 10.1038/488465a · DOI
  18. Atac, 2013, Skin and hair on-a-chip: In vitro skin models versus ex vivo tissue maintenance with dynamic perfusion, Lab Chip, 13, 3555, 10.1039/c3lc50227a · DOI · Paper page
  19. Torisawa, 2014, Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro, Nat. Methods, 11, 663, 10.1038/nmeth.2938 · DOI · Paper page
  20. Griep, 2013, BBB on chip: Microfluidic platform to mechanically and biochemically modulate blood-brain barrier function, Biomed. Microdevices, 15, 145, 10.1007/s10544-012-9699-7 · DOI · Paper page
  21. Lee, 2019, Advances in dynamic microphysiological organ-on-a-chip: Design principle and its biomedical application, J. Ind. Eng. Chem., 71, 65, 10.1016/j.jiec.2018.11.041 · DOI
  22. Nelson, 2020, A 96-well format microvascularized human lung-on-a-chip platform for microphysiological modeling of fibrotic diseases, Lab Chip, 20, 3601, 10.1039/D0LC00644K · DOI
  23. Zhang, 2018, A 3D human lung-on-a-chip model for nanotoxicity testing, Toxicol. Res., 7, 1048, 10.1039/C8TX00156A · DOI · Paper page
  24. Zamprogno, 2021, Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane, Commun. Biol., 4, 168, 10.1038/s42003-021-01695-0 · DOI · Paper page
  25. Gard, 2021, High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitro, Sci. Rep., 11, 14961, 10.1038/s41598-021-94095-7 · DOI
  26. Toh, 2009, A microfluidic 3D hepatocyte chip for drug toxicity testing, Lab Chip, 9, 2026, 10.1039/b900912d · DOI · Paper page
  27. Jing, 2020, Establishment and Application of Peristaltic Human Gut-Vessel Microsystem for Studying Host-Microbial Interaction, Front. Bioeng. Biotechnol., 8, 272, 10.3389/fbioe.2020.00272 · DOI
  28. Wang, 2017, Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening, Biotechnol. Bioeng., 114, 184, 10.1002/bit.26045 · DOI · Paper page
  29. Wevers, 2018, A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport, Fluids Barriers CNS, 15, 23, 10.1186/s12987-018-0108-3 · DOI · Paper page
  30. Papademetriou, I., Vedula, E., Charest, J., and Porter, T. (2018). Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier. PLoS ONE, 13. · DOI · Paper page
  31. Marsano, 2016, Beating heart on a chip: A novel microfluidic platform to generate functional 3D cardiac microtissues, Lab Chip, 16, 599, 10.1039/C5LC01356A · DOI · Paper page
  32. Zhang, 2016, Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip, Biomaterials, 110, 45, 10.1016/j.biomaterials.2016.09.003 · DOI · Paper page
  33. Faulkner-Jones, A., Zamora, V., Hortigon-Vinagre, M.P., Wang, W., Ardron, M., Smith, G.L., and Shu, W. (2022). A Bioprinted Heart-on-a-Chip with Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Evaluation. Bioengineering, 9. · DOI
  34. Jayne, 2021, Direct laser writing for cardiac tissue engineering: A microfluidic heart on a chip with integrated transducers, Lab Chip, 21, 1724, 10.1039/D0LC01078B · DOI
  35. Jeon, 2020, Side-effect test of sorafenib using 3-D skin equivalent based on microfluidic skin-on-a-chip, J. Ind. Eng. Chem., 82, 71, 10.1016/j.jiec.2019.09.044 · DOI · Paper page
  36. Kim, K., Jeon, H.M., Choi, K.C., and Sung, G.Y. (2020). Testing the Effectiveness of Curcuma longa Leaf Extract on a Skin Equivalent Using a Pumpless Skin-on-a-Chip Model. Int. J. Mol. Sci., 21. · DOI
  37. Zhang, 2021, Construction of a high fidelity epidermis-on-a-chip for scalable in vitro irritation evaluation, Lab Chip, 21, 3804, 10.1039/D1LC00099C · DOI · Paper page
  38. Llenas, M., Paoli, R., Feiner-Gracia, N., Albertazzi, L., Samitier, J., and Caballero, D. (2021). Versatile Vessel-on-a-Chip Platform for Studying Key Features of Blood Vascular Tumors. Bioengineering, 8. · DOI
  39. Abudupataer, 2019, Bioprinting a 3D vascular construct for engineering a vessel-on-a-chip, Biomed. Microdevices, 22, 10, 10.1007/s10544-019-0460-3 · DOI
  40. Zhou, 2021, Fabrication of PDMS microfluidic devices using nanoclay-reinforced Pluronic F-127 as a sacrificial ink, Biomed. Mater., 16, 045005, 10.1088/1748-605X/abe55e · DOI
  41. Tian, 2020, A Novel Tissue-Based Liver-Kidney-on-a-Chip Can Mimic Liver Tropism of Extracellular Vesicles Derived from Breast Cancer Cells, Biotechnol. J., 15, e1900107, 10.1002/biot.201900107 · DOI
  42. Selahi, 2021, Lymphangion-chip: A microphysiological system which supports co-culture and bidirectional signaling of lymphatic endothelial and muscle cells, Lab Chip, 22, 121, 10.1039/D1LC00720C · DOI
  43. Zhou, 2018, Extracellular matrix in lung development, homeostasis and disease, Matrix Biol., 73, 77, 10.1016/j.matbio.2018.03.005 · DOI · Paper page
  44. Xu, 2020, Assessment of Air Pollutant PM2.5 Pulmonary Exposure Using a 3D Lung-on-Chip Model, ACS Biomater. Sci. Eng., 6, 3081, 10.1021/acsbiomaterials.0c00221 · DOI
  45. Moradi, 2020, Microfluidic organ-on-a-chip models of human liver tissue, Acta Biomater., 116, 67, 10.1016/j.actbio.2020.08.041 · DOI · Paper page
  46. Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 · DOI · Paper page
  47. Jeon, 2021, In vitro hepatic steatosis model based on gut-liver-on-a-chip, Biotechnol. Prog., 37, e3121, 10.1002/btpr.3121 · DOI
  48. Chen, 2017, Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk, Biotechnol. Bioeng., 114, 2648, 10.1002/bit.26370 · DOI · Paper page
  49. Lee, 2018, Gut–liver on a chip toward an in vitro model of hepatic steatosis, Biotechnol. Bioeng., 115, 2817, 10.1002/bit.26793 · DOI · Paper page
  50. 2015, The human gut resistome, Philos. Trans. R. Soc. Lond. B Biol. Sci., 370, 20140087, 10.1098/rstb.2014.0087 · DOI · Paper page
  51. Compare, 2012, Gut--liver axis: The impact of gut microbiota on non alcoholic fatty liver disease, Nutr. Metab. Cardiovasc. Dis., 22, 471, 10.1016/j.numecd.2012.02.007 · DOI · Paper page
  52. Sung, 2011, Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model, Lab Chip, 11, 389, 10.1039/C0LC00273A · DOI · Paper page
  53. Benson, 2013, Impedance-based cell monitoring: Barrier properties and beyond, Fluids Barriers CNS, 10, 5, 10.1186/2045-8118-10-5 · DOI · Paper page
  54. Thuenauer, 2014, Microfluidic approaches for epithelial cell layer culture and characterisation, Analyst, 139, 3206, 10.1039/C4AN00056K · DOI
  55. Henry, 2019, Non-invasive sensing of transepithelial barrier function and tissue differentiation in organs-on-chips using impedance spectroscopy, Lab Chip, 19, 452, 10.1039/C8LC00129D · DOI · Paper page
  56. Cardoso, 2010, Looking at the blood-brain barrier: Molecular anatomy and possible investigation approaches, Brain Res. Rev., 64, 328, 10.1016/j.brainresrev.2010.05.003 · DOI · Paper page
  57. Kim, 2015, Collagen-based brain microvasculature model in vitro using three-dimensional printed template, Biomicrofluidics, 9, 024115, 10.1063/1.4917508 · DOI · Paper page
  58. Jeong, 2018, A Three-Dimensional Arrayed Microfluidic Blood-Brain Barrier Model With Integrated Electrical Sensor Array, IEEE Trans. Biomed. Eng., 65, 431, 10.1109/TBME.2017.2773463 · DOI
  59. Park, 2019, Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies, Nat. Commun., 10, 2621, 10.1038/s41467-019-10588-0 · DOI · Paper page
  60. Hirose, 2019, Evidence for hormonal control of heart regenerative capacity during endothermy acquisition, Science, 364, 184, 10.1126/science.aar2038 · DOI · Paper page
  61. Visone, R., Gilardi, M., Marsano, A., Rasponi, M., Bersini, S., and Moretti, M. (2016). Cardiac Meets Skeletal: What’s New in Microfluidic Models for Muscle Tissue Engineering. Molecules, 21. · DOI
  62. Grosberg, 2011, Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip, Lab Chip, 11, 4165, 10.1039/c1lc20557a · DOI · Paper page
  63. Agarwal, 2013, Microfluidic heart on a chip for higher throughput pharmacological studies, Lab Chip, 13, 3599, 10.1039/c3lc50350j · DOI · Paper page
  64. Sun, L., Chen, Z., Xu, D., and Zhao, Y. (2022). Electroconductive and Anisotropic Structural Color Hydrogels for Visual Heart-on-a-Chip Construction. Adv. Sci., e2105777. · DOI
  65. Gotz, 2012, Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: Activating enzymes (Phase I), Exp. Derm., 21, 358, 10.1111/j.1600-0625.2012.01486.x · DOI
  66. He, 2021, A Colorimetric Dermal Tattoo Biosensor Fabricated by Microneedle Patch for Multiplexed Detection of Health-Related Biomarkers, Adv. Sci., 8, e2103030, 10.1002/advs.202103030 · DOI · Paper page
  67. Lukacs, B., Bajza, A., Kocsis, D., Csorba, A., Antal, I., Ivan, K., Laki, A.J., and Erdo, F. (2019). Skin-on-a-Chip Device for Ex Vivo Monitoring of Transdermal Delivery of Drugs-Design, Fabrication, and Testing. Pharmaceutics, 11. · DOI
  68. Autier, 2008, Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor, Arch. Derm., 144, 886, 10.1001/archderm.144.7.886 · doi:10.1001/archderm.144.7.886
  69. Lee, 2021, Bone Microvasculature: Stimulus for Tissue Function and Regeneration, Tissue Eng. Part B Rev., 27, 313, 10.1089/ten.teb.2020.0154 · DOI
  70. Asaumi, 2021, Photolithography-free Vessel-on-a-chip to Simulate Tumor Cell Extravasation, Sens. Mater., 33, 241
  71. Salipante, 2021, Blood vessel-on-a-chip examines the biomechanics of microvasculature, Soft Matter, 18, 117, 10.1039/D1SM01312B · DOI
  72. Basile, 2012, Pathophysiology of acute kidney injury, Compr. Physiol., 2, 1303, 10.1002/cphy.c110041 · DOI · Paper page
  73. Xiao, 2017, A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle, Nat. Commun., 8, 14584, 10.1038/ncomms14584 · DOI · Paper page
  74. Novak, 2020, Robotic fluidic coupling and interrogation of multiple vascularized organ chips, Nat. Biomed. Eng., 4, 407, 10.1038/s41551-019-0497-x · DOI · Paper page
  75. Herland, 2020, Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips, Nat. Biomed. Eng., 4, 421, 10.1038/s41551-019-0498-9 · DOI · Paper page
  76. Baert, 2020, A multi-organ-chip co-culture of liver and testis equivalents: A first step toward a systemic male reprotoxicity model, Hum. Reprod., 35, 1029, 10.1093/humrep/deaa057 · DOI
  77. Maschmeyer, 2015, Chip-based human liver-intestine and liver-skin co-cultures—A first step toward systemic repeated dose substance testing in vitro, Eur. J. Pharm. Biopharm., 95, 77, 10.1016/j.ejpb.2015.03.002 · DOI · Paper page
  78. Rowland, 2011, Physiologically-based pharmacokinetics in drug development and regulatory science, Annu. Rev. Pharm. Toxicol., 51, 45, 10.1146/annurev-pharmtox-010510-100540 · DOI · Paper page
  79. Chi, 2020, High-Throughput Tumor-on-a-Chip Platform to Study Tumor-Stroma Interactions and Drug Pharmacokinetics, Adv. Healthc. Mater., 9, e2000880, 10.1002/adhm.202000880 · DOI
  80. Liu, 2020, Investigation of absorption, metabolism and toxicity of ginsenosides compound K based on human organ chips, Int. J. Pharm., 587, 119669, 10.1016/j.ijpharm.2020.119669 · DOI · Paper page
  81. Shinha, 2020, A pharmacokinetic-pharmacodynamic model based on multi-organ-on-a-chip for drug-drug interaction studies, Biomicrofluidics, 14, 044108, 10.1063/5.0011545 · DOI · Paper page
  82. Skardal, 2020, Drug compound screening in single and integrated multi-organoid body-on-a-chip systems, Biofabrication, 12, 025017, 10.1088/1758-5090/ab6d36 · DOI · Paper page
  83. Gokaltun, 2017, Recent advances in nonbiofouling PDMS surface modification strategies applicable to microfluidic technology, Technology, 5, 1, 10.1142/S2339547817300013 · DOI · Paper page
  84. Wagner, 2006, The emerging nanomedicine landscape, Nat. Biotechnol., 24, 1211, 10.1038/nbt1006-1211 · DOI · Paper page
  85. Chen, 2021, Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine, Bioact. Mater., 6, 1012
  86. Lu, 2021, Organ-on-a-chip platforms for evaluation of environmental nanoparticle toxicity, Bioact. Mater., 6, 2801
  87. Davila, 2021, Microvessel-on-Chip Fabrication for the In Vitro Modeling of Nanomedicine Transport, ACS Omega, 6, 25109, 10.1021/acsomega.1c00735 · DOI
  88. Lee, 2021, 3D Microfluidic Platform and Tumor Vascular Mapping for Evaluating Anti-Angiogenic RNAi-Based Nanomedicine, ACS Nano, 15, 338, 10.1021/acsnano.0c05110 · DOI
  89. Egorov, 2021, Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems, Drug Deliv. Transl. Res., 11, 345, 10.1007/s13346-021-00929-2 · DOI
  90. Aleman, 2021, Microfluidic integration of regeneratable electrochemical affinity-based biosensors for continual monitoring of organ-on-a-chip devices, Nat. Protoc., 16, 2564, 10.1038/s41596-021-00511-7 · DOI · Paper page
  91. Shang, 2019, Chip modularity enables molecular information access from organ-on-chip devices with quality control, Sens. Actuators B Chem., 295, 30, 10.1016/j.snb.2019.05.030 · DOI
  92. Farooqi, 2020, Real-time physiological sensor-based liver-on-chip device for monitoring drug toxicity, J. Micromech. Microeng., 30, 115013, 10.1088/1361-6439/ababf4 · DOI

Cited by

See all 120

Metadata

Authors
Li, Z., Hui, J., Yang, P., & Mao, H.
Venue
Biosensors
Publisher
MDPI AG
Published
2022-05-27
Volume
12
Issue
6
Pages
370
ISSN
2079-6374 (ISSN-L)
OpenAlex
W4281999480
Cited by
120
References
35
FWCI
6.00
Type
journal article
Language
en
Open access
gold
Funders
  • National Key Research and Development Program, China (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
  • National Science Foundation, China (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
  • Shanghai Sailing Program (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
  • Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
  • China Postdoctoral Science Foundation (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.